CRI's new website that seeks to engage, educate, and empower patients and their loved ones to learn more about cancer immunotherapy as a treatment option across numerous tumor types.
Cancer patients, donors, scientists, and other supporters all stand behind the Cancer Research Institute. Read their stories and learn about what motivates each of us to keep fighting against cancer.
By running in a marathon or hosting a bake sale, you can make a real difference for our scientists in the fight against cancer and allow them to bring newer immunotherapies to more patients.
We gratefully accept donations made in memory or in honor of a loved one. Your gift will be acknowledged to whomever you specify.
A $1 million challenge to spur innovative solutions to challenges in cancer immunotherapy research.
Curious about the latest developments in cancer immunotherapy research? Listen in as leading scientists discuss immune-based treatments across numerous cancer types in our free "Cancer Immunotherapy and You" webinar series.
When the Cancer Research Institute was founded in 1953, we knew then that immune-based treatments would transform cancer medicine. In more than six decades since, we've made numerous groundbreaking discoveries that have given more patients new hope today.
CRI programs have been instrumental in pioneering the field and funding discoveries, offering hope for the ultimate prevention and treatment of cancer using our immune system.
Watch interviews with our scientists to learn more about their groundbreaking research and its impact on patients, roundtable discussions from experts at CRI conferences and meetings, as well as public service announcements highlighting CRI's role in the field of cancer immunotherapy.
When Sharon Belvin learned that she had advanced melanoma at 22 years old, she enrolled in a CRI-funded clinical trial for a new antibody therapy called anti-CTLA-4. Today, the mother of two is still cancer free. Read more about her story and other cancer survivors who used these powerful new treatments called immunotherapies.
Stay up-to-date with the latest cancer immunotherapy news from CRI by signing up for our e-newsletter or alerts.